Cargando…

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

“clinical NEUroPROteomics of neurodegenerative diseases” (cNEUPRO) is a Specific Targeted Research Project (STREP) within the sixth framework program of the European Commission dedicated to the search for novel biomarker candidates for Alzheimer's disease and other neurodegenerative diseases. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Spitzer, Philipp, Klafki, Hans Wolfgang, Blennow, Kaj, Buée, Luc, Esselmann, Hermann, Herruka, Sanna-Kaisa, Jimenez, Connie, Klivenyi, Peter, Lewczuk, Piotr, Maler, Juan Manuel, Markus, Katrin, Meyer, Helmut E., Morris, Chris, Müller, Thorsten, Otto, Markus, Parnetti, Lucilla, Soininen, Hilkka, Schraen, Susanna, Teunissen, Charlotte, Vecsei, Laszlo, Zetterberg, Henrik, Wiltfang, Jens
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945639/
https://www.ncbi.nlm.nih.gov/pubmed/20886057
http://dx.doi.org/10.4061/2010/548145
_version_ 1782187230749523968
author Spitzer, Philipp
Klafki, Hans Wolfgang
Blennow, Kaj
Buée, Luc
Esselmann, Hermann
Herruka, Sanna-Kaisa
Jimenez, Connie
Klivenyi, Peter
Lewczuk, Piotr
Maler, Juan Manuel
Markus, Katrin
Meyer, Helmut E.
Morris, Chris
Müller, Thorsten
Otto, Markus
Parnetti, Lucilla
Soininen, Hilkka
Schraen, Susanna
Teunissen, Charlotte
Vecsei, Laszlo
Zetterberg, Henrik
Wiltfang, Jens
author_facet Spitzer, Philipp
Klafki, Hans Wolfgang
Blennow, Kaj
Buée, Luc
Esselmann, Hermann
Herruka, Sanna-Kaisa
Jimenez, Connie
Klivenyi, Peter
Lewczuk, Piotr
Maler, Juan Manuel
Markus, Katrin
Meyer, Helmut E.
Morris, Chris
Müller, Thorsten
Otto, Markus
Parnetti, Lucilla
Soininen, Hilkka
Schraen, Susanna
Teunissen, Charlotte
Vecsei, Laszlo
Zetterberg, Henrik
Wiltfang, Jens
author_sort Spitzer, Philipp
collection PubMed
description “clinical NEUroPROteomics of neurodegenerative diseases” (cNEUPRO) is a Specific Targeted Research Project (STREP) within the sixth framework program of the European Commission dedicated to the search for novel biomarker candidates for Alzheimer's disease and other neurodegenerative diseases. The ultimate goal of cNEUPRO is to identify one or more valid biomarker(s) in blood and CSF applicable to support the early and differential diagnosis of dementia disorders. The consortium covers all steps required for the discovery of novel biomarker candidates such as acquisition of high quality CSF and blood samples from relevant patient groups and controls, analysis of body fluids by various methods, and finally assay development and assay validation. Here we report the standardized procedures for diagnosis and preanalytical sample-handling within the project, as well as the status of the ongoing research activities and some first results.
format Text
id pubmed-2945639
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-29456392010-09-30 cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases Spitzer, Philipp Klafki, Hans Wolfgang Blennow, Kaj Buée, Luc Esselmann, Hermann Herruka, Sanna-Kaisa Jimenez, Connie Klivenyi, Peter Lewczuk, Piotr Maler, Juan Manuel Markus, Katrin Meyer, Helmut E. Morris, Chris Müller, Thorsten Otto, Markus Parnetti, Lucilla Soininen, Hilkka Schraen, Susanna Teunissen, Charlotte Vecsei, Laszlo Zetterberg, Henrik Wiltfang, Jens Int J Alzheimers Dis Review Article “clinical NEUroPROteomics of neurodegenerative diseases” (cNEUPRO) is a Specific Targeted Research Project (STREP) within the sixth framework program of the European Commission dedicated to the search for novel biomarker candidates for Alzheimer's disease and other neurodegenerative diseases. The ultimate goal of cNEUPRO is to identify one or more valid biomarker(s) in blood and CSF applicable to support the early and differential diagnosis of dementia disorders. The consortium covers all steps required for the discovery of novel biomarker candidates such as acquisition of high quality CSF and blood samples from relevant patient groups and controls, analysis of body fluids by various methods, and finally assay development and assay validation. Here we report the standardized procedures for diagnosis and preanalytical sample-handling within the project, as well as the status of the ongoing research activities and some first results. SAGE-Hindawi Access to Research 2010-09-19 /pmc/articles/PMC2945639/ /pubmed/20886057 http://dx.doi.org/10.4061/2010/548145 Text en Copyright © 2010 Philipp Spitzer et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Spitzer, Philipp
Klafki, Hans Wolfgang
Blennow, Kaj
Buée, Luc
Esselmann, Hermann
Herruka, Sanna-Kaisa
Jimenez, Connie
Klivenyi, Peter
Lewczuk, Piotr
Maler, Juan Manuel
Markus, Katrin
Meyer, Helmut E.
Morris, Chris
Müller, Thorsten
Otto, Markus
Parnetti, Lucilla
Soininen, Hilkka
Schraen, Susanna
Teunissen, Charlotte
Vecsei, Laszlo
Zetterberg, Henrik
Wiltfang, Jens
cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
title cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
title_full cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
title_fullStr cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
title_full_unstemmed cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
title_short cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
title_sort cneupro: novel biomarkers for neurodegenerative diseases
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945639/
https://www.ncbi.nlm.nih.gov/pubmed/20886057
http://dx.doi.org/10.4061/2010/548145
work_keys_str_mv AT spitzerphilipp cneupronovelbiomarkersforneurodegenerativediseases
AT klafkihanswolfgang cneupronovelbiomarkersforneurodegenerativediseases
AT blennowkaj cneupronovelbiomarkersforneurodegenerativediseases
AT bueeluc cneupronovelbiomarkersforneurodegenerativediseases
AT esselmannhermann cneupronovelbiomarkersforneurodegenerativediseases
AT herrukasannakaisa cneupronovelbiomarkersforneurodegenerativediseases
AT jimenezconnie cneupronovelbiomarkersforneurodegenerativediseases
AT klivenyipeter cneupronovelbiomarkersforneurodegenerativediseases
AT lewczukpiotr cneupronovelbiomarkersforneurodegenerativediseases
AT malerjuanmanuel cneupronovelbiomarkersforneurodegenerativediseases
AT markuskatrin cneupronovelbiomarkersforneurodegenerativediseases
AT meyerhelmute cneupronovelbiomarkersforneurodegenerativediseases
AT morrischris cneupronovelbiomarkersforneurodegenerativediseases
AT mullerthorsten cneupronovelbiomarkersforneurodegenerativediseases
AT ottomarkus cneupronovelbiomarkersforneurodegenerativediseases
AT parnettilucilla cneupronovelbiomarkersforneurodegenerativediseases
AT soininenhilkka cneupronovelbiomarkersforneurodegenerativediseases
AT schraensusanna cneupronovelbiomarkersforneurodegenerativediseases
AT teunissencharlotte cneupronovelbiomarkersforneurodegenerativediseases
AT vecseilaszlo cneupronovelbiomarkersforneurodegenerativediseases
AT zetterberghenrik cneupronovelbiomarkersforneurodegenerativediseases
AT wiltfangjens cneupronovelbiomarkersforneurodegenerativediseases